Finance

Lists
Why is APLLTD up 2,05%?
Dive Deeper
APLLTD:NSE
Alembic Pharmaceuticals Ltd
832,00 ₹
+2,05%
(+16,75) 1D
5 հոկ, 15:30:01 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for APLLTD...
Open
815,25 ₹
High
836,80 ₹
Low
812,20 ₹
Mkt. cap
163,54 մլրդ
Avg. vol.
192,85 հզր
Volume
282,53 հզր
Dividend
1,44%
Quarterly dividend
3,00 ₹
Ex-dividend date
29 հլս, 2026 թ.
P/E ratio
23,59
52-wk high
998,00 ₹
52-wk low
635,80 ₹
EPS
35,27 ₹
Shares outstanding
188,50 մլն
No. of employees
17 հզր
Open
815,25 ₹
High
836,80 ₹
Low
812,20 ₹
Mkt. cap
163,54 մլրդ
Avg. vol.
192,85 հզր
Volume
282,53 հզր
Dividend
1,44%
Quarterly dividend
3,00 ₹
Ex-dividend date
29 հլս, 2026 թ.
P/E ratio
23,59
52-wk high
998,00 ₹
52-wk low
635,80 ₹
EPS
35,27 ₹
Shares outstanding
188,50 մլն
No. of employees
17 հզր
News stories
From web sources and news partners
The Daily News | Texas' Oldest Newspaper
The Daily News | Texas' Oldest Newspaper
·
9 րոպե առաջ
NYSE logo in New York City
Value The Markets
Value The Markets
·
3 ժամ առաջ
Taylor Devices (NASDAQ: TAYD) Reports Q1 Sales Decline
About Alembic Pharmaceuticals Ltd
CEO-
Employees17,2 հզր
Founded1907
Headquarters-
Sector-
Website-
Last report
04 օգս, 2026 թ.
Fiscal period
Q1 2027
EPS / Est. (INR)
8,80 ₹ / 7,79 ₹
+13,00%beat
Revenue / Est. (INR)
21,50 մլրդ / 18,97 մլրդ
+13,34%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
19,10 մլրդ
18,76 մլրդ
18,48 մլրդ
21,50 մլրդ
Cost of goods sold
5,16 մլրդ
5,29 մլրդ
6,27 մլրդ
6,20 մլրդ
Cost of revenue
5,16 մլրդ
5,29 մլրդ
6,27 մլրդ
6,20 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,38 մլրդ
4,33 մլրդ
4,39 մլրդ
4,74 մլրդ
Operating expense
11,55 մլրդ
11,34 մլրդ
10,85 մլրդ
12,96 մլրդ
Total operating expenses
16,71 մլրդ
16,63 մլրդ
17,11 մլրդ
19,16 մլրդ
Operating income
2,40 մլրդ
2,13 մլրդ
1,36 մլրդ
2,34 մլրդ
Other non operating income
69,00 մլն
154,90 մլն
-285,60 մլն
149,30 մլն
EBT including unusual items
2,24 մլրդ
1,61 մլրդ
1,19 մլրդ
2,22 մլրդ
EBT excluding unusual items
2,24 մլրդ
2,04 մլրդ
1,37 մլրդ
2,22 մլրդ
Income tax expense
400,00 մլն
295,40 մլն
-829,00 մլն
495,00 մլն
Effective tax rate
17,88%
18,29%
-69,88%
22,31%
Other operating expenses
6,41 մլրդ
6,21 մլրդ
5,56 մլրդ
7,24 մլրդ
Net income
1,85 մլրդ
1,33 մլրդ
2,03 մլրդ
1,73 մլրդ
Net profit margin
9,67%
7,09%
10,97%
8,05%
Earnings per share
9,40
8,51
11,57
8,80
Interest and investment income
-
-
8,60 մլն
-
Interest expense
-242,30 մլն
-233,10 մլն
-225,60 մլն
-276,10 մլն
Net interest expenses
-242,30 մլն
-233,10 մլն
-217,00 մլն
-276,10 մլն
Depreciation and amortization charges
760,70 մլն
801,20 մլն
885,90 մլն
977,10 մլն
EBITDA
3,15 մլրդ
2,78 մլրդ
2,12 մլրդ
3,09 մլրդ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps